A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Multicenter Phase II Trial of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyg075 ◽

2003 ◽

Vol 33 (8) ◽

pp. 371-376 ◽

Cited By ~ 18

Author(s):

K. Sato

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

Study Group ◽

Multicenter Phase ◽

Clinical Study Group

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0306-9 ◽

2009 ◽

Vol 117 (3) ◽

pp. 591-598 ◽

Cited By ~ 23

Author(s):

Elmar Stickeler ◽

Maximilian Klar ◽

Dirk Watermann ◽

Annette Geibel ◽

Martha Földi ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase ◽

Line Therapy

The effect of pathological response of multicenter phase II trial of fluorouracil, epirubicin, cyclophosphamide (FEC 100) followed by docetaxel (DOC 75) in primary operable breast cancer (JBCRG01: Japan Breast Cancer Research Group)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80390-3 ◽

2006 ◽

Vol 4 (2) ◽

pp. 156 ◽

Cited By ~ 2

Author(s):

S. Nakamura ◽

Toi ◽

Y. Takatsuka ◽

K. Kuroi ◽

H. Iwata ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Operable Breast Cancer ◽

Pathological Response ◽

Breast Cancer Research ◽

Multicenter Phase ◽

Primary Operable Breast Cancer

Capecitabine: The new standard in metastatic breast cancer failing anthracycline and taxane-containing chemotherapy? Mature results of a large multicenter phase II trial

European Journal of Cancer ◽

10.1016/s0959-8049(01)81191-6 ◽

2001 ◽

Vol 37 ◽

pp. S191 ◽

Cited By ~ 20

Author(s):

P. Reichardt ◽

G. von Minckwitz ◽

H.J. Lück ◽

P.C. Thuss-Patience ◽

W. Jonat ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9591-y ◽

2007 ◽

Vol 108 (2) ◽

pp. 241-250 ◽

Cited By ~ 322

Author(s):

Keun Seok Lee ◽

Hyun Cheol Chung ◽

Seock Ah Im ◽

Yeon Hee Park ◽

Chul Soo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Polymeric Micelle ◽

Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.696 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 696-696

Author(s):

K. Haider ◽

G. Kornek ◽

W. Kwasny ◽

D. Depisch ◽

T. Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Pretreated Patients

Neoadjuvant paclitaxel for operable breast cancer: Multicenter phase II trial with clinical outcomes, analysis of mutation of the class I β-tubulin gene

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.609 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 609-609

Author(s):

N. Sato ◽

M. Sano ◽

M. Hino ◽

M. Kimura ◽

M. Fujimori ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Outcomes ◽

Phase Ii ◽

Phase Ii Trial ◽

Operable Breast Cancer ◽

Class I ◽

Outcomes Analysis ◽

Tubulin Gene ◽

Multicenter Phase ◽

Β Tubulin

A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG07): The efficacy and its correlation with circulating endothelial cells.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.618 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 618-618

Author(s):

T. Ueno ◽

N. Masuda ◽

S. Kamigaki ◽

T. Morimoto ◽

S. Nakamura ◽

...

Keyword(s):

Breast Cancer ◽

Endothelial Cells ◽

Estrogen Receptor ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Circulating Endothelial Cells ◽

Multicenter Phase ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Investigational New Drugs ◽

10.1007/s10637-008-9166-8 ◽

2008 ◽

Vol 27 (2) ◽

pp. 166-172 ◽

Cited By ~ 11

Author(s):

G. Schilling ◽

M. Bruweleit ◽

N. Harbeck ◽

C. Thomssen ◽

K. Becker ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Open Label ◽

Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2− Early-stage Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2018.06.012 ◽

2018 ◽

Vol 18 (6) ◽

pp. 474-480 ◽

Cited By ~ 8

Author(s):

Takashi Kuwayama ◽

Seigo Nakamura ◽

Naoki Hayashi ◽

Toshimi Takano ◽

Koichiro Tsugawa ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Early Stage ◽

Early Stage Breast Cancer ◽